FDA Mandates New Boxed Warning For TNF Inhibitors
This article was originally published in The Pink Sheet Daily
Executive Summary
Four TNF-alpha blocker marketers asked to add Medication Guides and strengthen education programs to increase awareness of risk of fungal infections.
You may also be interested in...
FDA Cites Abbott’s Humira Psoriasis Ad: Patient Does Not Exhibit Severe Disease
Warning letter for Humira ad reprises agency interest in clear identification of appropriate patients.
FDA Cites Abbott’s Humira Psoriasis Ad: Patient Does Not Exhibit Severe Disease
Warning letter for Humira ad reprises agency interest in clear identification of appropriate patients.
JAKs Are Better? Oral Inhibitors Could Beat Injected Biologics In RA
Class is gaining strength in other indications, too.